glp-1 market Overview: Agonists and the Obesity Market | Blog Weighing the GLP-1 Market

There are currently 2,190 pending lawsuits in the federal litigation against GLP-1 drug manufacturers

3 Targeting Glutamine Metabolism for Cancer Therapy Due to its central role in many cancers, glutaminolysis is becoming an increasingly prominent target for cancer therapy

The Journal of Pharmacology and Experimental Therapeutics has retracted this article. In September 2024, Athira Pharmas LIFT-AD trial of fosgonimetona clinical derivative of Dihexafailed to meet primary and secondary endpoints in 312 mild-to-moderate Alzheimers patients

NPJ Aging Mech

Supports your bodys natural calorie processing

In this connection, the development of improved recognition components, analytical methods, and diagnostic kits can play a pivotal role in ensuring food safety amidst the ever-changing mycotoxin challenges